Do you want to read an article? Please log in or register.
Efficacy and Safety of Obeticholic Acid as Second-Line Therapy in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis
Further Publications
Related content
Inflammatory Bowel Disease
Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of Adult Patients with Moderate-to-Severe Crohn's Disease: A Systematic Literature Review and Network Meta-Analysis
Adv Ther
Schreiber S, Danese S, Colombel JF, Hisamatsu T, Irving PM, Park H, Kim DH, Lee YN, Hanauer SB
doi: 10.1007/s12325-025-03447-6
RECOMMENDED
Inflammatory Bowel Disease
Efficacy of 5-Aminosalicylic Acid Continuation versus Discontinuation in Patients with Ulcerative Colitis Escalated to Advanced Therapy: A Systematic Review and Meta-Analysis of Adjusted Effect Estimates
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
J Crohns Colitis
Sul HH, Gewehr DM, Kang H, Junior OR, Ungaro RC, Bernstein CN
doi: 10.1093/ecco-jcc/jjaf202
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis
Lancet Gastroenterol Hepatol
Thakur ER, Khasawneh M, Moayyedi P, Black CJ, Ford AC
doi: 10.1016/S2468-1253(25)00238-9
Gastrointestinal Cancer
Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment Comparisons
Adv Ther
Ajani JA, Wang K, Nikolaidis GF, Coaquira Castro J, Augusto Novis de Figueiredo M, Sun JM, Soulanis K, Tasoulas A, Zhan L
doi: 10.1007/s12325-025-03410-5
Inflammatory Bowel Disease
Efficacy, safety, and outcomes of endoscopic submucosal dissection for inflammatory bowel disease-associated colorectal neoplasia: a systematic review and meta-analysis comparing Asian and Western outcomes
J Crohns Colitis
Martins M, Nunes MV, Macedo G, Pioche M, Jacques J, Geyl S, Shimamura Y, Marques M, Lopes S, Cr Nunes A, Faria-Ramos I, Calabrese G, Sferrazza S, Rimondi A, Murino A, Despott E, De Sire R, Maselli R, Santos-Antunes J, Sousa-Pinto B, Morais R
doi: 10.1093/ecco-jcc/jjag082
Further Publications
Comparative efficacy and safety of risankizumab versus ustekinumab in moderate-to-severe Crohn's disease: a systematic review and meta-analysis
Minerva Gastroenterol (Torino)
Moon S, Choi YJ, Shin S
doi: 10.23736/S2724-5985.26.04084-2
Helicobacter Pylori
Susceptibility-Guided Versus Empirical First-Line Therapy of Helicobacter pylori Infection in Adults: A Systematic Review and Meta-Analysis
Helicobacter
Rocha MC, Gaspar T, Bernardes C, Nunes PP
doi: 10.1111/hel.70125
Helicobacter Pylori
Efficacy and Safety of Quadruple Therapy With Semisynthetic Tetracycline for Helicobacter pylori Eradication: A Meta-Analysis
J Gastroenterol Hepatol
Guo QQ, Zhang J, Zhu XJ, Li WY, Zhao DY, Liang MQ, Yan R, Shi YQ
doi: 10.1111/jgh.70348
Inflammatory Bowel Disease
Efficacy and Safety of Second-Line Advanced Therapy After Vedolizumab in Ulcerative Colitis: A Multicenter Cohort Study From the GETAID
United European Gastroenterol J
Calméjane L, Reenaers C, Gay C, Amiot A, Nuzzo A, Vuitton L, Atanasiu C, Stefanescu C, Altwegg R, Guillo L, Serrero M, Bouguen G, Nachury M, Cosquer GL, Roblin X, Abitbol V, Hammoudi N, Simon M, Fumery M, Savoye G, Benezech A, Cavicchi M, Charkaoui M, Buisson A, Caron B, Coffin B, Geyl S, Goutorbe F, Hupé M, Vidon M, Laharie D, Kirchgesner J, Uzzan M, GETAID‐AFTER‐VEDO Study Group
doi: 10.1002/ueg2.70203